Philogen SpA

As of December 31, 2025, Philogen SpA carries a market capitalization of 938.55M, placing it among publicly traded companies globally. Its enterprise value stands at 570.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Philogen SpA's next confirmed earnings release is scheduled for March 25, 2027.

As of December 31, 2025, Philogen SpA has 40.28M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Philogen SpA maintains a current ratio of 7.76, meaning it holds 7.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Philogen SpA's stock has declined approximately 11.09% over the past 52 weeks. The 50-day moving average sits at 22.74, while the 200-day moving average is 22.47.

As of December 31, 2025, Philogen SpA holds 379.22M in cash and equivalents against 10.88M in total debt, resulting in a net debt position of -127.20M. Total book value stands at 373.86M, with working capital of 346.59M providing operational flexibility.